El-Husseiny M, Daas L, Langenbucher A, Seitz B
Klinik für Augenheilkunde, Universitätsklinikum des Saarlandes, Homburg.
Experimentelle Ophthalmologie, Universitätsklinikum des Saarlandes, Homburg.
Klin Monbl Augenheilkd. 2016 Jun;233(6):722-6. doi: 10.1055/s-0042-108653. Epub 2016 Jun 17.
Implantation of intracorneal ring segments (ICRS) using a femtosecond laser is a minimally invasive procedure which represents a reliable option to widen the spectrum of the stage-related therapy of keratoconus in patients with contact lens intolerance, or with post-LASIK-keratectasia or pellucide marginale degeneration (PMD).
From August 2011 to September 2015, 84 eyes of 69 patients were implanted with ICRS. 74 eyes were implanted with INTACS-SK (Intacs, Addition Technology, Inc.), and 10 eyes were implanted with KeraRing SI6 (Mediaphacos Ltda.). The indication is taken in the presence of a clear central cornea and the patients had to fulfill the corneal diagnostic tests required for implantation. Tunnel creation should nowadays only be carried out by femtosecond laser, in order to avoid intra- and postoperative complications.
Three months after surgery, the INTACS-SK group showed an increase in uncorrected distance visual acuity (logMAR) from 0.99 ± 0.35 to 0.29 ± 0.17. The KeraRing SI6 group showed an increase in uncorrected distance visual acuity (logMAR) from 0.93 ± 0.4 to 0.41 ± 0.34. The keratometric values were reduced in both groups.
Uncorrected and corrected distance visual acuity can be improved by implantation of the ICRS. Progression of ectasia seems to be retarded. Consistent follow-up visits at close intervals are necessary to identify complications at an early stage. However, larger case series and a longer postoperative observation period are required. Complications after ICRS implantation are rare, due to strict patient selection and modern surgical techniques.
使用飞秒激光植入角膜内环片(ICRS)是一种微创手术,对于那些不耐受隐形眼镜、患有准分子激光原位角膜磨镶术(LASIK)后角膜扩张或周边透明性角膜变性(PMD)的圆锥角膜患者而言,它是一种可靠的分期治疗选择,可拓宽治疗范围。
2011年8月至2015年9月,69例患者的84只眼植入了ICRS。74只眼植入了INTACS-SK(Intacs,Addition Technology公司),10只眼植入了KeraRing SI6(Mediaphacos Ltda.)。植入指征为中央角膜透明,且患者必须完成植入所需的角膜诊断检查。如今,为避免术中及术后并发症发生,应仅使用飞秒激光制作隧道。
术后3个月,INTACS-SK组未矫正远视力(logMAR)从0.99±0.35提高至0.29±0.17。KeraRing SI6组未矫正远视力(logMAR)从0.93±0.4提高至0.41±0.34。两组的角膜曲率值均降低。
植入ICRS可提高未矫正和矫正后的远视力。角膜扩张的进展似乎得到了延缓。需要定期进行密切随访,以便早期发现并发症。然而,还需要更大规模的病例系列和更长的术后观察期。由于严格的患者选择和现代手术技术,ICRS植入术后的并发症很少见。